Search results

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Brain metastases remain a defining challenge in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). Therapies that can control disease in the central nervous system

Making its debut on 06/20/2013, smart beta exchange traded fund Invesco Global ex-US High Yield Corporate Bond ETF (PGHY) provides investors broad exposure to the High-Yield/Junk Bond ETFs category

UnitedHealth Group Incorporated UNH is facing sustained margin pressure within its Medicare Advantage (MA) business as medical costs continue to trend higher. Elevated utilization, driven by a

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Designed to provide broad exposure to the Consumer Discretionary - Broad segment of the equity market, the Invesco S&P 500 Equal Weight Consumer Discretionary ETF (RSPD) is a passively managed

Rigetti Computing RGTI continues to deepen its foothold in the emerging quantum computing ecosystem with the sale of its 9-qubit Novera QPU to the University of Saskatchewan (USask). The system will

Designed to provide broad exposure to the Consumer Discretionary - Broad segment of the equity market, the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) is a passively managed

Kodiak Sciences KOD reported fourth-quarter 2025 loss of $1.04 per share, wider than the Zacks Consensus Estimate of a loss of $1.02. The company had incurred a loss of 84 cents per share in the

Bitfarms BITF reported a net loss of 31 cents per share from continuing operations for the fourth quarter of 2025, which is wider than the Zacks Consensus Estimate of a net loss of 4 cents. The

The upcoming report from Constellation Brands (STZ) is expected to reveal quarterly earnings of $1.74 per share, indicating a decline of 33.8% compared to the year-ago period. Analysts forecast